Predictors of Success for Adults with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy: A Retrospective Review

Bibliographic Details
Main Author: Ausich, Mary Kathryn
Language:English
Published: The Ohio State University / OhioLINK 2010
Online Access:http://rave.ohiolink.edu/etdc/view?acc_num=osu1267709402
id ndltd-OhioLink-oai-etd.ohiolink.edu-osu1267709402
record_format oai_dc
spelling ndltd-OhioLink-oai-etd.ohiolink.edu-osu12677094022021-08-03T05:58:46Z Predictors of Success for Adults with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy: A Retrospective Review Ausich, Mary Kathryn Background/ Objective: Complications can ensue from uncontrolled type 1 diabetes, resulting in compromised quality and duration of life, and increased health care costs. The provision of insulin is achieved by multiple daily injections (MDI) or by insulin pump through continuous subcutaneous insulin infusion (CSII). The primary objective was to determine the difference between hemoglobin A1c (HbA1c) before and after the switch from MDI to CSII therapy. Methods: In this retrospective medical record review, paired t-tests were used for all of the pre-post comparisons. To determine whether external factors were related to a successful reduction in HbA1c after pump initiation, the pre-post HbA1c difference was used as the outcome in a linear regression model, and potential patient characteristic covariates were evaluated univariately for their predictive ability: age, gender, duration of diabetes, age at diagnosis, average insulin pre-pump units (absolute and per kg body weight), weight, insulin and pump types, and the presence of various complications. Of the 107 subjects initially identified, 42 subjects met inclusion criteria. Results: The average HbA1c of participants decreased by 0.55% from pre-pump values (P = 0.0001), the average daily insulin dose per kilogram of body weight decreased by 0.061 U/kg, (P = 0.0029), and weight decreased by 0.07 kg. (P=0.86). None of the continuous or categorical variables were found to be statistically significant at predicting a pre- to post-reduction in HbA1c levels. Conclusions: This study suggests that all study participants, regardless of patient characteristics, benefited from the transition from MDI to CSII therapy. 2010-08-23 English text The Ohio State University / OhioLINK http://rave.ohiolink.edu/etdc/view?acc_num=osu1267709402 http://rave.ohiolink.edu/etdc/view?acc_num=osu1267709402 unrestricted This thesis or dissertation is protected by copyright: all rights reserved. It may not be copied or redistributed beyond the terms of applicable copyright laws.
collection NDLTD
language English
sources NDLTD
author Ausich, Mary Kathryn
spellingShingle Ausich, Mary Kathryn
Predictors of Success for Adults with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy: A Retrospective Review
author_facet Ausich, Mary Kathryn
author_sort Ausich, Mary Kathryn
title Predictors of Success for Adults with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy: A Retrospective Review
title_short Predictors of Success for Adults with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy: A Retrospective Review
title_full Predictors of Success for Adults with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy: A Retrospective Review
title_fullStr Predictors of Success for Adults with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy: A Retrospective Review
title_full_unstemmed Predictors of Success for Adults with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy: A Retrospective Review
title_sort predictors of success for adults with type 1 diabetes on continuous subcutaneous insulin infusion therapy: a retrospective review
publisher The Ohio State University / OhioLINK
publishDate 2010
url http://rave.ohiolink.edu/etdc/view?acc_num=osu1267709402
work_keys_str_mv AT ausichmarykathryn predictorsofsuccessforadultswithtype1diabetesoncontinuoussubcutaneousinsulininfusiontherapyaretrospectivereview
_version_ 1719428816041934848